Oral s3x users are more likely to develop throat cancer, according to a study.
According to research by Hisham Mehanna, professor at the University of Birmingham’s Institute of Cancer and Genomic Sciences, oral s3x is currently the main risk factor for throat cancer. Oropharyngeal…
Read more